The estimated Net Worth of Suzanne C Winter is at least $4.25 Millón dollars as of 30 November 2023. Ms Winter owns over 65,390 units of Accuray Inc stock worth over $2,698,528 and over the last 5 years she sold ARAY stock worth over $728,282. In addition, she makes $821,651 as Pres at Accuray Inc.
Ms has made over 12 trades of the Accuray Inc stock since 2020, according to the Form 4 filled with the SEC. Most recently she sold 65,390 units of ARAY stock worth $161,513 on 30 November 2023.
The largest trade she's ever made was selling 65,390 units of Accuray Inc stock on 30 November 2023 worth over $161,513. On average, Ms trades about 14,145 units every 59 days since 2019. As of 30 November 2023 she still owns at least 1,369,811 units of Accuray Inc stock.
You can see the complete history of Ms Winter stock trades at the bottom of the page.
Suzanne Winter M.B.A. is the Pres at Accuray Inc.
As the Pres of Accuray Inc, the total compensation of Ms A at Accuray Inc is $821,651. There are 5 executives at Accuray Inc getting paid more, with Ali Pervaiz having the highest compensation of $5,183,662.
Ms A is 58, she's been the Pres of Accuray Inc since . There are 9 older and 5 younger executives at Accuray Inc. The oldest executive at Accuray Inc is Elizabeth Davila, 75, who is the Independent Director.
Suzanne's mailing address filed with the SEC is 1310, Chesapeake Terrace, Sunnyvale, Santa Clara County, California, 94089, United States.
Over the last 18 years, insiders at Accuray Inc have traded over $37,863,458 worth of Accuray Inc stock and bought 806,995 units worth $5,047,672 . The most active insiders traders include International Investment Ho..., Robert S Weiss y Euan Thomson. On average, Accuray Inc executives and independent directors trade stock every 24 days with the average trade being worth of $62,792. The most recent stock trade was executed by Ali Pervaiz on 4 September 2024, trading 8,404 units of ARAY stock currently worth $17,312.
accuray incorporated (nasdaq: aray) is a radiation oncology company that develops, manufactures and sells precise, innovative tumor treatment solutions that set the standard of care with the aim of helping patients live longer, better lives. the company's leading-edge technologies deliver the full range of radiation therapy and radiosurgery treatments. for more information, please visit www.accuray.com. for career opportunities, please visit http://www.accuray.com/careers.
Accuray Inc executives and other stock owners filed with the SEC include: